Molnupiravir represents a important development in the battle against COVID-19, functioning as an oral antiviral medication. Early designed to combat influenza, its unique mechanism of action – introducing errors into the viral genetic code – has demonstrated effectiveness in reducing the risk of severe illness and hospitalization in high-risk